Prescribing intelligence for ADHD therapies
Prescriptions for CNS stimulants to treat ADHD are increasing. In England there was a 9% growth in patient numbers mid-2017 to mid-2018, with over a million prescription items issued, predominantly to males aged 7-18.
Medications are grouped into 12 hour or 8 hour modified release methylphenidate, immediate release methylphenidate, Lisdexamfetamine, Atomoxetine and Guafacine.
The RxIndex to the right monitors the performance of all modified release methylphenidate brands, the most frequently prescribed drugs for ADHD.
Additional resources relating to ADHD prescribing
Additional resources coming soon!